Epidemiological Profile of Hiv/Hbv Co-Infection among Patients Attending Hospital Consultations in Brazzaville

Authors

  • Roch Bredin Bissala Nkounkou Faculty of Health Sciences, Marien Ngouabi University, Republic of Congo Author
  • Paola Candyse Tsimba Lemba Faculty of Health Sciences, Marien Ngouabi University, Republic of Congo Author
  • Luc Magloire Anicet Boumba Pointe-Noire Research Zone, National Institute of Health Research, Pointe-Noire, Republic of Congo Author
  • Esther Nina Ontsira Ngoyi Bacteriology and Virology Laboratory, Brazzaville University Hospital Center, Brazzaville, Republic of Congo Author
  • Michel Valentin Sapoulou Gbala Medical Biology Laboratory, Djiri General Hospital, Brazzaville, Republic of Congo Author
  • Carole Else Eboumbou Moukoko Pathogenes, Epidemiology and Clinical Trials Laboratory, Faculty of Medecine and Pharmaceutical Sciences, University of Douala, Republic of Congo Author
  • Didier Hober Paul Boulanger Center, A. Calmette Hospital, Prof. J. Leclerc Boulevard, Lille, France Author

DOI:

https://doi.org/10.47363/JVRR/2025(6)180

Keywords:

Epidemiological, Hiv/Hbv, Co-Infection

Abstract

HIV and HBV infections remain a serious public health problem in sub-Saharan countries. From time to time, we see rapidly increasing prevalence rates, and co-infection remains a major issue that public authorities around the world, and in Africa in particular, are working to resolve. Our cross-sectional, descriptive study was conducted among 130 patients who came for consultation and attended the laboratory department of the Djiri General Hospital in Brazzaville. After collecting plasma samples, rapid screening tests were used. Positive cases were confirmed using the ELISA technique. Of the 130 participants, 8.46% and 4.62% were diagnosed as HIV-positive and HBV-positive, respectively, with an HIV/HBV co-infection prevalence of 9.09%. We found no significant association between the two infections and socio-demographic characteristics. Our results showed low prevalence of both infections, with a predominance in the 12-35 age group, i.e., young people. In view of the results, it would be important to intensify actions targeting young girls, as women remain the most vulnerable sex likely to contract either HIV or HBV in the present study

Author Biographies

  • Roch Bredin Bissala Nkounkou, Faculty of Health Sciences, Marien Ngouabi University, Republic of Congo

    Roch Bredin Bissala Nkounkou, Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Republic of Congo. 

  • Paola Candyse Tsimba Lemba, Faculty of Health Sciences, Marien Ngouabi University, Republic of Congo


    Faculty of Health Sciences, Marien Ngouabi University, Republic of Congo

  • Luc Magloire Anicet Boumba, Pointe-Noire Research Zone, National Institute of Health Research, Pointe-Noire, Republic of Congo


    Pointe-Noire Research Zone, National Institute of Health Research, Pointe-Noire, Republic of Congo

  • Esther Nina Ontsira Ngoyi, Bacteriology and Virology Laboratory, Brazzaville University Hospital Center, Brazzaville, Republic of Congo

    Bacteriology and Virology Laboratory, Brazzaville University Hospital Center, Brazzaville, Republic of Congo

  • Michel Valentin Sapoulou Gbala, Medical Biology Laboratory, Djiri General Hospital, Brazzaville, Republic of Congo

    Medical Biology Laboratory, Djiri General Hospital, Brazzaville, Republic of Congo

  • Carole Else Eboumbou Moukoko, Pathogenes, Epidemiology and Clinical Trials Laboratory, Faculty of Medecine and Pharmaceutical Sciences, University of Douala, Republic of Congo

    Pathogenes, Epidemiology and Clinical Trials Laboratory, Faculty of Medecine and Pharmaceutical Sciences, University of Douala, Republic of Congo

  • Didier Hober, Paul Boulanger Center, A. Calmette Hospital, Prof. J. Leclerc Boulevard, Lille, France


    Paul Boulanger Center, A. Calmette Hospital, Prof. J. Leclerc Boulevard, Lille, France

Downloads

Published

2025-11-05